Marek Gierlotka

Head of Cardiology Department, Professor of Medicine (Cardiology)

Opole University

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Marek Gierlotka serves as the Head of the Cardiology Department at Opole University in Poland. His research focuses on cardiovascular risk assessment, management of patients with acute heart failure, and the implications of metabolic syndrome. Recent articles include investigations into medication strategies for high-risk cardiovascular patients and the impact of pre-existing conditions on stroke outcomes.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Introduction Blood lipoprotein(a) (Lp(a)) levels have been observed to be inversely correlated with type 2 diabetes (T2D). In this Mendelian Randomization (MR) study, the causal impact of genetically-predicted Lp(a) on T2D was assessed. Material and methods A two-sample MR analysis was conducted. Data were obtained from UKBiobank and FinnGen consortia. Primary analysis was based on inverse-variance-weighted mean (IVM) approach. Results No statistically significant association between the genetically predicted levels of Lp(a) and T2D was detected (p=0.362) in IVM analysis involving data of 563,420 patients. Conclusions Genetically predicted Lp(a) concentration does not appear to causally influence the risk of T2D.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (20)

Marlena Broncel

Medical University of Lodz

POLAND

Marek Gierlotka

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.

SCORE2 charts assign a different risk category than the underlying model in a large portion of Polish primary care patients

Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure

Association between Lp(a) and T2D: A Mendelian Randomization Study

Ischaemic pontine stroke as a manifestation of left atrial myxoma

The Impact of Previously Diagnosed Depression on Early and One-Year Mortality in Patients with Acute Ischemic Stroke in Opole Province, Poland

Combined Use of GDF-15 and NT-Pro BNP for Outcome Prediction in Patients with Acute Heart Failure

Clinical characteristics and 12-month outcomes of patients with myocardial infarction with nonobstructive coronary arteries before and during the COVID-19 pandemic.

Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data

Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies

Subarachnoid Haemorrhage—Incidence of Hospitalization, Management and Case Fatality Rate—In the Silesian Province, Poland, in the Years 2009–2019

Comorbidities and clinical outcomes of a lung cancer screening trial participants with chronic obstructive pulmonary disease in three-year follow-up

Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study

Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study

Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.

Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts' opinion. The compromise between EBM and possibilities in healthcare

Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design

Collaborators (20)

Marlena Broncel

Michał Skrzypek

Krzysztof Dyrbus

Tadeusz Osadnik

Filip M. Szymanski

Witold Streb

Kern Adam

Agata Bąk

Jacek Kubica

Agata Bielecka-Dabrowa

Anetta Lasek-Bal

Beata Labuz-Roszak

Piotr Jankowski

Magdalena Stachera

Peter Penson

Maciej Tomaszewski

Katarzyna Sznajder

Thomas MacDonald

Witold Rzyman

Mateusz Lejawa

Make your next move.